Literature DB >> 24951955

HoxA10 induces proliferation in human prostate carcinoma PC-3 cell line.

Baoxiu Li1, Xiaofei Cao, Chengyin Weng, Yong Wu, Xisheng Fang, Xiaoshi Zhang, Guolong Liu.   

Abstract

The objectives of this study were to examine the expression levels of Homeobox A10 (HoxA10) in prostate cancer cells and to study the molecular mechanism of HoxA10-mediated regulation of prostate cancer cell growth and development. We investigated the effect of HoxA10 on cell proliferation by stably overexpressing or silencing HoxA10 in prostate cancer PC-3 cell line using lentiviral vectors. Quantitative real-time PCR and western blotting analysis were used to compare the expressions of HoxA10 in prostate cancer cell lines and normal prostate epithelium. Cancer cell proliferation was examined by MTT assay and colony formation assay. The levels of HoxA10 expression were significantly increased in prostate cancer cell lines and tissues compared to those in normal prostate epithelium. Overexpression of HoxA10 in PC-3 cells induced significant cancer cell proliferation, whereas silencing of HoxA10 expression by RNAi resulted in decreased proliferation rates. HoxA10 was highly expressed in prostate cancer cells and tissues, suggesting its functional involvement in cancer cell proliferation. We successfully overexpressed or silenced HoxA10 in prostate cancer PC-3 cell line and discovered that the levels of HoxA10 directly correlate with cancer cell proliferation. These findings contribute to a better understanding of the regulatory mechanism of HoxA10 in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24951955     DOI: 10.1007/s12013-014-0065-7

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  9 in total

1.  HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma.

Authors:  Manoela Carrera; Carolina C Bitu; Carine Ervolino de Oliveira; Nilva K Cervigne; Edgard Graner; Aki Manninen; Tuula Salo; Ricardo D Coletta
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 2.  Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.

Authors:  Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Wataru Yasui
Journal:  Cancer Sci       Date:  2015-07-07       Impact factor: 6.716

3.  LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.

Authors:  Ming Shao; Qiankun Yang; Weitao Zhu; Huifang Jin; Jing Wang; Jie Song; Yongkui Kong; Xianping Lv
Journal:  Mol Cancer       Date:  2018-12-13       Impact factor: 27.401

4.  HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway.

Authors:  Wenchao Chen; Gang Wu; Yuanzeng Zhu; Wei Zhang; Han Zhang; Yang Zhou; Peichun Sun
Journal:  Cancer Manag Res       Date:  2019-07-15       Impact factor: 3.989

5.  HOXA10 knockdown inhibits proliferation, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells through HDAC1.

Authors:  Yi Zhang; Jie Chen; Shan-Shan Wu; Meng-Jiao Lv; Yong-Sheng Yu; Zheng-Hao Tang; Xiao-Hua Chen; Guo-Qing Zang
Journal:  Cancer Manag Res       Date:  2019-07-26       Impact factor: 3.989

6.  HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.

Authors:  Chenlong Song; Yang Han; Huan Luo; Zhiwei Qin; Zhengqian Chen; Yuan Liu; Su Lu; Huimin Sun; Chongzhi Zhou
Journal:  Cancer Med       Date:  2019-07-30       Impact factor: 4.452

7.  Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.

Authors:  Aida Barreiro-Alonso; María Cámara-Quílez; Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; Olaia Martínez-Iglesias; Angélica Figueroa; María-Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

8.  JPX and LINC00641 ncRNAs expression in prostate tissue: a case-control study.

Authors:  Roshanak S Sajjadi; Mohammad Hossein Modarressi; Mohammad Amin Tabatabaiefar
Journal:  Res Pharm Sci       Date:  2021-08-19

9.  Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Authors:  Young-Bem Se; Seung Hyun Kim; Ji Young Kim; Ja Eun Kim; Yun-Sik Dho; Jin Wook Kim; Yong Hwy Kim; Hyun Goo Woo; Se-Hyuk Kim; Shin-Hyuk Kang; Hak Jae Kim; Tae Min Kim; Soon-Tae Lee; Seung Hong Choi; Sung-Hye Park; Il Han Kim; Dong Gyu Kim; Chul-Kee Park
Journal:  Cancer Res Treat       Date:  2016-07-19       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.